Rigel Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Rigel Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 3% to $116,882,000. The net income raised on -$25,091,000 and profit margin reached -21%. Total operating expenses were $130,263,000.
Profit Margin
| 2014 | 8.25M | -90.90M | -1101.92% |
|---|---|---|---|
| 2015 | 28.89M | -51.46M | -178.11% |
| 2016 | 20.38M | -69.21M | -339.58% |
| 2017 | 4.48M | -77.99M | -1739.34% |
| 2018 | 44.50M | -70.48M | -158.35% |
| 2019 | 59.28M | -66.54M | -112.24% |
| 2020 | 108.62M | -30.39M | -27.98% |
| 2021 | 149.23M | -17.91M | -12% |
| 2022 | 120.24M | -61.59M | -51.23% |
| 2023 | 116.88M | -25.09M | -21.47% |
RIGL Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 116.88M | 120.24M | 149.23M | 108.62M | 59.28M | 44.50M | 4.48M | 20.38M | 28.89M | 8.25M |
Cost of revenue | 7.11M | 1.74M | 1.08M | 895K | 906K | 287K | 46.26M | 63.44M | 62.82M | 67.69M |
Gross profit | 109.77M | 118.49M | 148.15M | 107.72M | 58.38M | 44.22M | -41.78M | -43.06M | -33.93M | -59.44M |
Operating exp. | ||||||||||
Research and development | 24.52M | 60.27M | 65.23M | 60.10M | 52.88M | 46.90M | 46.26M | 63.44M | 62.82M | 67.69M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 130.26M | 172.72M | 157.12M | 136.69M | 127.47M | 116.90M | 84.1M | 84.35M | 80.63M | 99.49M |
Operating income | -20.49M | -54.23M | -8.97M | -28.97M | -69.09M | -72.68M | -79.61M | -69.74M | -51.74M | -91.24M |
Other income (expenses), net | -4.6M | -4.34M | -8.33M | -771K | 2.19M | 2.20M | 1.62M | -5.68M | 279K | 341K |
Income before tax | -25.09M | -58.57M | -17.30M | -29.74M | -66.89M | -70.48M | -77.99M | -69.21M | -51.46M | -90.90M |
Income tax expense | 0 | 3.02M | 605K | 647K | -348K | 2.20M | -2.08M | 4.30M | -1.71M | -2.7M |
Net income | -25.09M | -61.59M | -17.91M | -30.39M | -66.54M | -70.48M | -77.99M | -69.21M | -51.46M | -90.90M |
Earnings per share | ||||||||||
Basic EPS | -1.44 | -0.36 | -0.11 | -1.76 | -0.4 | -0.44 | -6.17 | -0.73 | -5.82 | -10.37 |
Diluted EPS | -1.44 | -0.36 | -0.11 | -1.76 | -0.4 | -0.44 | -6.17 | -0.73 | -5.82 | -10.37 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |